牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

百洋医药（301015）

4.9

综合诊断：4.9分打败了79%的股票！

卖出
减持
中性
增持
买入

短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
中期趋势：
-
长期趋势：
已有205家主力机构披露2024-12-31报告期持股数据，持仓量总计3809.08万股，占流通A股7.25%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

2.6分

6.3分

5.5分

2.5分

7.3分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：2.6技术面打败了23%的股票技术面评分前10的股票

近期的平均成本为19.40元。

技术面得分最高的股票

平均成本

近期的平均成本为19.40元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"19.40","date":1744878385,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势跑输大盘，跑输行业平均水平。

[{"date":"2025.04.18","stock":"-1.02","trade":"-0.37","ind":"0.23"},{"date":"2025.04.17","stock":"0.51","trade":"0.74","ind":"-0.16"},{"date":"2025.04.16","stock":"-1.32","trade":"-1.23","ind":"-0.85"},{"date":"2025.04.15","stock":"0.15","trade":"0.11","ind":"-0.27"},{"date":"2025.04.14","stock":"0.77","trade":"1.30","ind":"0.51"},{"date":"2025.04.11","stock":"0.21","trade":"-0.33","ind":"0.82"},{"date":"2025.04.10","stock":"2.42","trade":"1.99","ind":"2.25"},{"date":"2025.04.09","stock":"0.32","trade":"1.27","ind":"1.22"},{"date":"2025.04.08","stock":"5.16","trade":"1.75","ind":"0.64"},{"date":"2025.04.07","stock":"-15.63","trade":"-10.73","ind":"-9.66"},{"date":"2025.04.03","stock":"-0.97","trade":"0.20","ind":"-1.40"},{"date":"2025.04.02","stock":"0.37","trade":"0.05","ind":"0.09"},{"date":"2025.04.01","stock":"2.72","trade":"2.74","ind":"-0.01"},{"date":"2025.03.31","stock":"-2.65","trade":"-1.80","ind":"-0.97"},{"date":"2025.03.28","stock":"-1.38","trade":"-1.13","ind":"-0.57"},{"date":"2025.03.27","stock":"1.49","trade":"0.27","ind":"0.23"},{"date":"2025.03.26","stock":"-0.14","trade":"0.06","ind":"-0.05"},{"date":"2025.03.25","stock":"0.00","trade":"1.13","ind":"-0.43"},{"date":"2025.03.24","stock":"0.37","trade":"-1.69","ind":"0.07"},{"date":"2025.03.21","stock":"-8.26","trade":"-1.72","ind":"-1.76"},{"date":"2025.03.20","stock":"-0.09","trade":"-0.71","ind":"-0.91"}]

百洋医药,深证成指,医药商业指数

压力支撑

该股压力位为19.43元，支撑位为19.16元。

[{"text":"\u538b\u529b\u4f4d","value":"19.43","date":1744905600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"19.16","date":1744905600,"color":"0x0b52a1"}]

多空趋势

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：6.3资金面打败了92%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力筹码很集中，呈高度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

医药商业行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：04月18日 20:30

机构今日流向(万元)	-761.09	机构5日流向(万元)	-2216.20
机构10日流向(万元)	-3710.52	机构20日流向(万元)	-8385.37

机构持仓

2024-12-31 与 2024-06-30 相比，主力机构持仓量减少3194.5万股，其中基金净减仓3家，主力净减仓3家，请投资者中长期谨慎为宜。

截止2024-12-31，共205家主力机构（基金205家），持仓量总计3809.08万股，占流通A股7.25%
其中，基金持仓与2024-06-30相比：
增仓：37家，增持 173.17万股
减仓：40家，减持 946.51万股
新出现在主力名单中：107家，持有979.53万股
从主力名单中消失：110家，原持有3400.69万股

消息面诊股

诊断结果：5.5消息面打败了40%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	募资投向	公司购买资产	2025-02-20
一般消息	重大事项	关联交易	2025-02-20
一般消息	重大事项	关联交易	2025-02-10
一般消息	股东大会	临时股东大会	2025-01-24
一般消息	高管变动	个人原因	2024-12-17
一般消息	重大事项	关联交易	2024-12-10
一般消息	重大事项	关联交易	2024-11-25
一般消息	重大事项	关联交易	2024-11-22
一般消息	重大事项	公司股东股份解押	2024-11-22
一般消息	重大事项	关联交易	2024-09-20
一般消息	重大事项	公司股东股份解押	2024-08-30
一般消息	分红转增	不分配不转增	2024-08-28
一般消息	重大事项	关联交易	2024-08-09
一般消息	重大事项	公司股东股份解押	2024-07-30
一般消息	重大事项	关联交易	2024-07-12
一般消息	重大事项	关联交易	2024-07-09
利好	重大事项	参股拟上市公司或非上市公司金融机构	2024-06-30
利好	分红转增	10派7.62元(含税)	2024-04-23

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	0条	2条
利空	0条	0条	0条

行业面诊股

诊断结果：2.5行业面打败了36%的股票医药商业行业最新资金流向

近10日来该行业走势总体向下，接近大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势总体向下，接近大盘。

[{"date":"2025.04.18","price":"0.23","value":"-0.37"},{"date":"2025.04.17","price":"-0.16","value":"0.74"},{"date":"2025.04.16","price":"-0.85","value":"-1.23"},{"date":"2025.04.15","price":"-0.27","value":"0.11"},{"date":"2025.04.14","price":"0.51","value":"1.30"},{"date":"2025.04.11","price":"0.82","value":"-0.33"},{"date":"2025.04.10","price":"2.25","value":"1.99"},{"date":"2025.04.09","price":"1.22","value":"1.27"},{"date":"2025.04.08","price":"0.64","value":"1.75"},{"date":"2025.04.07","price":"-9.66","value":"-10.73"},{"date":"2025.04.03","price":"-1.40","value":"0.20"},{"date":"2025.04.02","price":"0.09","value":"0.05"},{"date":"2025.04.01","price":"-0.01","value":"2.74"},{"date":"2025.03.31","price":"-0.97","value":"-1.80"},{"date":"2025.03.28","price":"-0.57","value":"-1.13"},{"date":"2025.03.27","price":"0.23","value":"0.27"},{"date":"2025.03.26","price":"-0.05","value":"0.06"},{"date":"2025.03.25","price":"-0.43","value":"1.13"},{"date":"2025.03.24","price":"0.07","value":"-1.69"},{"date":"2025.03.21","price":"-1.76","value":"-1.72"},{"date":"2025.03.20","price":"-0.91","value":"-0.71"}]

深证成指,医药商业行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	益丰药房	12.17%	0.18%	5.3分
2	大参林	10.92%	-0.35%	5.4分
3	南京医药	-1.19%	4.63%	5.2分
4	一心堂	-3.15%	1.81%	4.0分
5	上海医药	-3.54%	-0.48%	5.4分
6	国药股份	-4.44%	-0.65%	4.6分
7	老百姓	-5.17%	-0.48%	4.5分
8	英特集团	-5.22%	2.78%	5.0分
9	嘉事堂	-5.49%	0.83%	4.6分
10	重药控股	-5.83%	0.41%	4.7分
11	中国医药	-6.15%	0.10%	4.1分
12	国药一致	-6.59%	0.16%	4.9分
13	九州通	-6.65%	-1.04%	4.6分
14	浙江震元	-6.93%	1.32%	4.3分
15	海王生物	-6.97%	0.00%	4.4分
16	瑞康医药	-7.57%	0.72%	4.4分
17	鹭燕医药	-7.66%	1.95%	4.3分
18	柳药集团	-9.58%	0.66%	4.6分
19	第一医药	-9.60%	0.75%	4.7分
20	华人健康	-9.72%	0.91%	4.0分
21	开开实业	-9.78%	2.61%	4.6分
22	健之佳	-9.96%	0.40%	3.9分
23	人民同泰	-10.18%	1.67%	4.4分
24	达嘉维康	-11.68%	0.77%	4.3分
25	漱玉平民	-12.33%	1.04%	4.5分
26	药易购	-12.79%	1.20%	3.7分
27	国科恒泰	-13.01%	0.10%	4.5分
28	合富中国	-13.57%	1.43%	4.1分
29	百洋医药	-17.21%	-0.92%	4.9分
30	润达医疗	-20.89%	-3.85%	3.2分
31	塞力医疗	-23.85%	-2.33%	3.1分

<上一页 1 2 3 4 5 6 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：7.3基本面打败了94%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：中（97.5分）

基本面得分最高的股票

[ 截止日期：2024-09-30 ]公司经营

盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 1/72 ， 3/72。

[{"date":"2024-09-30","value":"25.75","vol":"5.85"},{"date":"2024-06-30","value":"13.90","vol":"4.44"},{"date":"2024-03-31","value":"6.03","vol":"2.30"},{"date":"2023-12-31","value":"26.41","vol":"7.23"},{"date":"2023-09-30","value":"20.40","vol":"7.28"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
净资产收益率(%)	25.75	13.90	6.03	26.41	20.40
行业(%)	5.85	4.44	2.30	7.23	7.28

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"35.72","vol":"17.89"},{"date":"2024-06-30","value":"31.53","vol":"17.84"},{"date":"2024-03-31","value":"29.75","vol":"17.80"},{"date":"2023-12-31","value":"29.98","vol":"17.83"},{"date":"2023-09-30","value":"29.33","vol":"18.09"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
销售毛利率(%)	35.72	31.53	29.75	29.98	29.33
行业(%)	17.89	17.84	17.80	17.83	18.09

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 13/72 ， 6/72。

[{"date":"2024-09-30","value":"2.65","vol":"2.06"},{"date":"2024-06-30","value":"-1.10","vol":"1.88"},{"date":"2024-03-31","value":"-1.50","vol":"4.80"},{"date":"2023-12-31","value":"0.72","vol":"4.27"},{"date":"2023-09-30","value":"-0.43","vol":"6.21"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
营业收入同比增长率(%)	2.65	-1.10	-1.50	0.72	-0.43
行业(%)	2.06	1.88	4.80	4.27	6.21

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"17.42","vol":"-50.40"},{"date":"2024-06-30","value":"21.89","vol":"-17.67"},{"date":"2024-03-31","value":"35.60","vol":"3.54"},{"date":"2023-12-31","value":"29.55","vol":"2.19"},{"date":"2023-09-30","value":"43.29","vol":"10.40"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
净利润同比增长率(%)	17.42	21.89	35.60	29.55	43.29
行业(%)	-50.40	-17.67	3.54	2.19	10.40

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 10/72 ， 15/72。

[{"date":"2024-09-30","value":"1.01","vol":"0.89"},{"date":"2024-06-30","value":"0.63","vol":"0.60"},{"date":"2024-03-31","value":"0.30","vol":"0.31"},{"date":"2023-12-31","value":"1.46","vol":"1.24"},{"date":"2023-09-30","value":"1.06","vol":"0.91"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
总资产周转率(次)	1.01	0.63	0.30	1.46	1.06
行业(次)	0.89	0.60	0.31	1.24	0.91

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"5.05","vol":"4.52"},{"date":"2024-06-30","value":"3.79","vol":"3.08"},{"date":"2024-03-31","value":"1.73","vol":"1.58"},{"date":"2023-12-31","value":"7.94","vol":"6.32"},{"date":"2023-09-30","value":"6.03","vol":"4.72"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
存货增长率(次)	5.05	3.79	1.73	7.94	6.03
行业(次)	4.52	3.08	1.58	6.32	4.72

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2024-09-30","value":"8.37","vol":"4.01"},{"date":"2024-06-30","value":"11.00","vol":"6.46"},{"date":"2024-03-31","value":"8.21","vol":"-3.83"},{"date":"2023-12-31","value":"14.46","vol":"10.23"},{"date":"2023-09-30","value":"0.68","vol":"2.62"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
现金流量净额/营业收入	8.37	11.00	8.21	14.46	0.68
行业	4.01	6.46	-3.83	10.23	2.62

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.67","vol":"0.77"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"2.14","vol":"1.02"},{"date":"2023-09-30","value":"","vol":"0.00"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
资本支出／折旧和摊销	-	1.67	-	2.14	-
行业	0.00	0.77	0.00	1.02	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 4/72 ， 23/72。

[{"date":"2024-09-30","value":"1.71","vol":"1.47"},{"date":"2024-06-30","value":"1.99","vol":"1.49"},{"date":"2024-03-31","value":"2.40","vol":"1.51"},{"date":"2023-12-31","value":"2.45","vol":"1.51"},{"date":"2023-09-30","value":"2.31","vol":"1.48"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
流动比率	1.71	1.99	2.40	2.45	2.31
行业	1.47	1.49	1.51	1.51	1.48

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"1.33","vol":"1.04"},{"date":"2024-06-30","value":"1.66","vol":"1.06"},{"date":"2024-03-31","value":"1.95","vol":"1.09"},{"date":"2023-12-31","value":"1.97","vol":"1.07"},{"date":"2023-09-30","value":"1.82","vol":"1.06"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
速动比率	1.33	1.66	1.95	1.97	1.82
行业	1.04	1.06	1.09	1.07	1.06

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 17/72 ， 16/72。

[{"date":"2024-09-30","value":"63.53","vol":"61.64"},{"date":"2024-06-30","value":"56.95","vol":"61.18"},{"date":"2024-03-31","value":"50.30","vol":"61.00"},{"date":"2023-12-31","value":"50.13","vol":"60.66"},{"date":"2023-09-30","value":"52.98","vol":"61.05"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
资产负债率(%)	63.53	56.95	50.30	50.13	52.98
行业(%)	61.64	61.18	61.00	60.66	61.05

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2024-09-30","value":"1.90","vol":"2.19"},{"date":"2024-06-30","value":"1.31","vol":"2.15"},{"date":"2024-03-31","value":"1.00","vol":"2.15"},{"date":"2023-12-31","value":"1.00","vol":"2.12"},{"date":"2023-09-30","value":"1.12","vol":"2.07"}]

	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
产权比率 (%)	1.90	1.31	1.00	1.00	1.12
行业(%)	2.19	2.15	2.15	2.12	2.07

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
华泰金融(HK)	2025-01-27	买入
华泰证券	2025-01-24	买入

机构预测

机构预测该股2024年每股收益与前一年相同，长期投资价值一般。

[{"date":"2020","yellowRectValue":"2.73","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"4.22","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"5.07","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"6.56","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"8.43","blueLineValue":"1.60","type":"YC"}]

[百洋医药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]